Ikena Oncology Inc expected to post a loss of 35 cents a share - Earnings Preview

ImageneBio

06/08/2024 18:49

* Ikena Oncology Inc  IKNA.OQ   IKNA.O  is expected to show
a fall
in quarterly revenue when it reports  results on August 8
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Ikena Oncology Inc is
for a
loss of 35 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $4.00​, above​ its last closing price of $1.63. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.41       -0.41      -0.33     Beat    20
 Jan. 1 2024               -0.43      -0.47     Missed  -9.8
 Sep. 30 2023  -0.42       -0.43      -0.40     Beat    7​
 Jan. 1 0001   -0.46                  -0.44             7.3
 ​​Mar.        -0.47       -0.47      -0.39     Beat    16.6
 31 2023                                                
 Dec. 31 2022  -0.53       -0.48      -0.40     Beat    16.1​
 Sep. 30 2022  -0.48       -0.50      -0.48     Beat    3.1
 Jan. 1 0001   -0.47       -0.49      -0.57     Missed  -16.8
 This summary was machine generated August 6 at 17:49 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)